Advanced search
Publication Cover
Current Medical Research and Opinion Volume 27, 2011 - Issue 6
Submit an article Journal homepage
754
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Long-term treatment outcomes with lisdexamfetamine dimesylate for adults with attention-deficit/hyperactivity disorder stratified by baseline severity

Lawrence GinsbergRed Oak Psychiatry Associates, PA, Houston, TX, USACorrespondence[email protected]
,
Alain KaticClaghorn Research Clinic, Houston, TX, USA
,
Ben AdeyiShire Development Inc., Wayne, PA, USA
,
Bryan DirksShire Development Inc., Wayne, PA, USA
,
Thomas BabcockShire Development Inc., Wayne, PA, USA
,
Robert LasserShire Development Inc., Wayne, PA, USA
,
Brian SchecknerShire Development Inc., Wayne, PA, USA
&
Lenard A. AdlerNew York University School of Medicine and Psychiatry Service, New York VA Harbor Healthcare System, New York, NY, USA
 show all
Pages 1097-1107 | Accepted 25 Feb 2011, Published online: 28 Mar 2011

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Terje Torgersen, Bjorn Gjervan, Michael B Lensing & Kirsten Rasmussen. (2016) Optimal management of ADHD in older adults. Neuropsychiatric Disease and Treatment 12, pages 79-87.
Read now
Timothy E Wilens, Nicholas R Morrison & Jefferson Prince. (2011) An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert Review of Neurotherapeutics 11:10, pages 1443-1465.
Read now

Articles from other publishers (18)

José Ramón Gutiérrez-Casares, Cristina Segú-Vergés, Juncal Sabate Chueca, Tamara Pozo-Rubio, Mireia Coma, Carmen Montoto & Javier Quintero. (2023) In silico evaluation of the role of lisdexamfetamine on attention-deficit/hyperactivity disorder common psychiatric comorbidities: mechanistic insights on binge eating disorder and depression. Frontiers in Neuroscience 17.
Crossref
José Ramón Gutiérrez-Casares, Javier Quintero, Cristina Segú-Vergés, Pilar Rodríguez Monterde, Tamara Pozo-Rubio, Mireia Coma & Carmen Montoto. (2023) In silico clinical trial evaluating lisdexamfetamine’s and methylphenidate’s mechanism of action computational models in an attention-deficit/hyperactivity disorder virtual patients’ population. Frontiers in Psychiatry 14.
Crossref
Deepti Anbarasan, Gabriella Safyer & Lenard A. Adler. (2022) Updates in Pharmacologic Strategies in Adult Attention-Deficit/Hyperactivity Disorder. Child and Adolescent Psychiatric Clinics of North America 31:3, pages 553-568.
Crossref
Daria Taubin, Julia C. Wilson & Timothy E. Wilens. (2022) ADHD and Substance Use Disorders in Young People. Child and Adolescent Psychiatric Clinics of North America 31:3, pages 515-530.
Crossref
José Ramón Gutiérrez-Casares, Javier Quintero, Guillem Jorba, Valentin Junet, Vicente Martínez, Tamara Pozo-Rubio, Baldomero Oliva, Xavier Daura, José Manuel Mas & Carmen Montoto. (2021) Methods to Develop an in silico Clinical Trial: Computational Head-to-Head Comparison of Lisdexamfetamine and Methylphenidate. Frontiers in Psychiatry 12.
Crossref
Jacqueline Champagne, Benjamin Gardner & Eleanor J Dommett. (2019) Modelling predictors of UK undergraduates’ attitudes towards smart drugs. Trends in Neuroscience and Education 14, pages 33-39.
Crossref
María Eugenia Russi. (2018) Experiencia en la utilización de lisdexanfetamina en el manejo del TDAH de niños y adolescentes. Revista de Psiquiatría Infanto-Juvenil 35:3, pages 241-249.
Crossref
Jadwiga Najib, Dexter WimerJulie ZengKristina W LamNatalya RomanyakEva Paige MorganAnu Thadavila. (2017) Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder. Journal of Central Nervous System Disease 9, pages 117957351772809.
Crossref
James E. Frampton. (2016) Lisdexamfetamine: A Review in ADHD in Adults. CNS Drugs 30:4, pages 343-354.
Crossref
Mats Fredriksen & Dawn E. Peleikis. (2016) Long-Term Pharmacotherapy of Adults With Attention Deficit Hyperactivity Disorder: A Literature Review and Clinical Study. Basic & Clinical Pharmacology & Toxicology 118:1, pages 23-31.
Crossref
Terje Torgersen, Steinar Krokstad & Arne E. Vaaler. (2014) Factors associated with a positive occupational outcome during long-term central stimulant treatment in adult ADHD. ADHD Attention Deficit and Hyperactivity Disorders 6:4, pages 281-290.
Crossref
Jefferson B. Prince, Nicholas R. Morrison & Timothy E. Wilens. 2015. Attention-Deficit Hyperactivity Disorder in Adults and Children. Attention-Deficit Hyperactivity Disorder in Adults and Children 276 297 .
Ralf W. Dittmann, Esther Cardo, Peter Nagy, Colleen S. Anderson, Ben Adeyi, Beatriz Caballero, Paul Hodgkins, Richard Civil & David R. Coghill. (2014) Treatment Response and Remission in a Double-Blind, Randomized, Head-to-Head Study of Lisdexamfetamine Dimesylate and Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder. CNS Drugs 28:11, pages 1059-1069.
Crossref
Mats Fredriksen, Anne Halmøy, Stephen V. Faraone & Jan Haavik. (2013) Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: A review of controlled and naturalistic studies. European Neuropsychopharmacology 23:6, pages 508-527.
Crossref
Rakesh Jain, Thomas Babcock, Teodor Burtea, Bryan Dirks, Ben Adeyi, Brian Scheckner, Robert Lasser, John Renna & Don Duncan. (2013) Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use. Advances in Therapy 30:5, pages 472-486.
Crossref
Paul Hammerness. 2013. ADHD in Adults. ADHD in Adults 71 87 .
István Bitter, Anna Angyalosi & Pál Czobor. (2012) Pharmacological treatment of adult ADHD. Current Opinion in Psychiatry 25:6, pages 529-534.
Crossref
Paul G. Hammerness, Craig B. H. Surman & Ashley Chilton. (2011) Adult Attention-Deficit/Hyperactivity Disorder Treatment and Cardiovascular Implications. Current Psychiatry Reports 13:5, pages 357-363.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.